ArticleBMJ open2022

Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.

Noriyuki Okonogi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.